AI/ML Innovations Inc. (AIML.CN) traded at C$0.04 on 10 Mar 2026 during market hours, up 14.29% on the session. The AIML.CN stock move followed low-volume trading of 41,808 shares against an average of 445,507. We review valuation, technicals and Meyka AI model forecasts to set practical price targets and risks for Canadian-listed AIML.CN stock in the healthcare AI/ML niche.
AIML.CN stock snapshot and key metrics
AI/ML Innovations (AIML.CN) trades on the CNQ exchange in Canada at C$0.04. The one-day change shows a +14.29% move with volume of 41,808. Market cap equals about C$5.89 million and shares outstanding total 168,264,000.
Key reported metrics: EPS -0.03, PE -1.17, 50-day average price C$0.04, 200-day average C$0.05, year high C$0.12 and year low C$0.03.
Financial health and valuation of AIML.CN stock
AIML.CN shows thin revenue per share at C$0.00 and negative net income per share -0.03. Price to sales stands at 40.00 and price to book at 5.23, highlighting a valuation premium versus current fundamentals.
Balance metrics show a current ratio of 2.09 and cash per share C$0.0053, but operating cash flow per share is negative -0.0264. These figures point to working capital coverage but ongoing cash burn and thin sales.
Meyka AI grade and AIML.CN stock forecast
Meyka AI rates AIML.CN with a score of 62.33 out of 100, Grade B, suggestion HOLD. This grade factors in S&P 500 and sector comparison, financial growth, key metrics and analyst consensus.
Meyka AI’s forecast model projects a monthly price of C$0.02 and a yearly price of C$0.02 (C$0.02174). Against the current C$0.04, the model implies a downside of -50.00% monthly and -45.65% yearly. Forecasts are model-based projections and not guarantees.
Technical setup and trading signals for AIML.CN stock
Momentum and trend indicators show limited strength. RSI sits at 42.55, ADX at 16.43 indicating no clear trend, and CCI at -140.00 flagged as oversold. Bollinger Bands compress between C$0.03 and C$0.04.
Volume signals are weak: current volume equals 41,808 versus average 445,507, and OBV reads -714,810, suggesting poor buying follow-through on the spike. Traders should expect high volatility and low liquidity.
Sector context and competitive landscape
AI/ML Innovations sits in the Healthcare sector and the Medical – Healthcare Information Services industry. The sector shows mixed performance, with average price to sales and high dispersion. Compared with healthcare peers, AIML.CN displays weaker margins and a negative ROE around -3.31%.
Investors should weigh sector tailwinds for digital health against AIML.CN’s small market cap and limited revenue scale. See competitor comparisons on Investing.com for broader context source and benchmark tools source.
Risks, catalysts and AIML.CN stock price targets
Primary risks: limited revenue, negative EPS, thin trading liquidity and a small market cap near C$5.89 million. Operational disclosure and product adoption are critical catalysts for valuation change.
Price targets: pessimistic C$0.02 (-50.00%), base C$0.05 (+25.00%), and bullish C$0.12 (+200.00%, near the year high). These targets reflect scenarios tied to product adoption, funding, or further dilution. Adjust risk appetite accordingly.
Final Thoughts
AIML.CN stock trades at C$0.04 on CNQ with a sharp session gain but thin volume. Financials show negative earnings and a high price-to-sales multiple of 40.00, which creates valuation risk for small-cap investors. Technical indicators point to no clear trend and low liquidity. Meyka AI rates AIML.CN 62.33/100 (Grade B, HOLD) and its forecast model projects C$0.02 monthly and C$0.02 yearly, implying downside of roughly -50.00% to -45.65% from today’s price. Use the price targets above and watch product milestones, cash runway, and any funding or partnership news. For a short-term trader, volume and RSI shifts matter most. For a longer-term investor, proof of recurring revenue and clearer clinical or commercial traction should precede adding AIML.CN stock to a portfolio. Meyka AI, an AI-powered market analysis platform, provides this model-based view; forecasts are projections and not guarantees.
FAQs
What is the current price of AIML.CN stock?
AIML.CN stock trades at C$0.04 on CNQ as of 10 Mar 2026. Volume was 41,808 shares. The stock showed a session gain of 14.29%, but liquidity remains thin versus an average of 445,507 shares.
What does Meyka AI forecast for AIML.CN stock?
Meyka AI’s forecast model projects C$0.02 monthly and C$0.02 yearly for AIML.CN stock. That implies roughly -50.00% to -45.65% downside versus the current C$0.04. Forecasts are projections and not guarantees.
What are the main risks for AIML.CN stock?
Key risks for AIML.CN stock include negative earnings, thin liquidity, small market cap (C$5.89M), and reliance on product adoption. Dilution and limited disclosure increase downside risk for investors.
What price targets should investors consider for AIML.CN stock?
Consider a pessimistic target of C$0.02, a base target of C$0.05, and a bullish target of C$0.12. Targets reflect funding, revenue evidence, or positive product milestones. Adjust positions to risk tolerance.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)